First new brain tumour drug for 20 years could give children an extra 18 months with family
CHILDREN with deadly brain tumours could get an 18-month survival boost with the first new NHS drug for almost 20 years. The medicines watchdog has approved the gene-targeting drug combination of dabrafenib and trametinib for children with glioma brain …